{ }
001122334455554433221100
001122334455554433221100

ubs lowers bayer price target to 22 euros maintains neutral rating

UBS has reduced its price target for Bayer from 30 to 22 euros while maintaining a "Neutral" rating. Analyst Jo Walton cited a weak outlook for the Leverkusen-based company, resulting in a 16% decrease in the earnings forecast for 2025.
16:58 21.11.2024

UBS Lowers Bayer Price Target to 22 Euros Maintains Neutral Rating

UBS has reduced its price target for Bayer from 30 to 22 euros while maintaining a "Neutral" rating. Analyst Jo Walton cited a weak outlook for the Leverkusen-based company, resulting in a 16% decrease in the earnings forecast for 2025.
07:26 21.11.2024

ubs reduces bayer target price to 22 euros amid market decline

UBS has lowered its target price for Bayer to 22 euros, maintaining a 'Neutral' rating. The stock has seen a decline, with the last trading price at approximately 19.54 euros, reflecting a drop of 3.03%. Various trading venues report similar downward trends in Bayer's stock price.
06:26 21.11.2024

global pediatric healthcare market poised for significant growth through 2032

The Global Pediatric Healthcare market is projected to grow from $175.6 billion in 2024 to $290 billion by 2032, with a CAGR of 6.5%. Key players include Abbott, Pfizer, and Merck, focusing on pharmaceuticals, nutrition, medical devices, and vaccines across various applications like hospitals and homecare. The market is expanding rapidly in the Asia-Pacific region, while North America remains the dominant market.

DAX experiences slight decline amid ongoing sideways market movement

The DAX index fell 0.1% to 19,189, continuing its sideways movement after a 0.3% decline on Friday. It briefly peaked at 19,279 before dropping to a low of 19,092, with key resistance at 19,250 and support at 19,150. A breakdown below 19,000 could target the October low of 18,912.
08:30 19.11.2024

microsoft launches tailored ai models for manufacturing agriculture and finance sectors

Microsoft has launched a suite of specialized AI models tailored for manufacturing, agriculture, and finance, partnering with industry leaders like Siemens and Bayer. These models aim to enhance operational efficiency and regulatory compliance, addressing specific challenges faced by businesses in these sectors. By integrating AI into everyday operations, Microsoft seeks to accelerate adoption and drive measurable improvements in productivity and decision-making.

mediaire secures 12 million euros to enhance AI solutions for MRI diagnostics

Berlin-based startup mediaire has secured €12 million in funding to enhance its AI solutions for MRI diagnostics and expand internationally. The investment, led by LBO France, will support the development of innovative tools already in use in over 350 clinics across Europe, while strengthening partnerships with major healthcare players like Bayer and Sectra.

bayer reports significant losses and cuts guidance amid agricultural market challenges

Bayer"s stock plummeted over 12% following disappointing third-quarter results and a downward revision of its 2024 guidance, primarily due to struggles in its agriculture sector. The company reported a net loss of €4.18 billion, driven by significant write-downs in its agrochemicals division, which saw an 8.7% revenue decline. While the Pharmaceuticals and Consumer Health divisions showed some growth, overall expectations for 2024 remain cautious, with anticipated declines in profit and a commitment to cost-cutting measures.

Trump presidency poses risks and opportunities for Swiss pharmaceutical industry

The pharmaceutical and chemical sector constitutes about 40% of Swiss exports, with major companies like Roche and Novartis closely monitoring the implications of a potential second Trump presidency. While there are hopes for biomedical innovation, concerns about public trust in the industry and the impact of proposed healthcare policies loom large, especially regarding drug pricing and the role of scientific research. Trump's administration may also challenge global health initiatives and partnerships, particularly with China, complicating the landscape for Swiss pharmaceutical firms reliant on international trade.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.